Ferrante Karen Jean bought COGT
June 9, 2026 · Form 4 insider transaction
Ferrante Karen Jean bought 17,901 shares of Cogent Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,901
Price
$0.00
Total value
N/A
InsiderFerrante Karen Jean
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 11, 2026
Shares owned after17,901
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date.